Covid Tests And New Drugs To Drive Roche's Stock Growth

Roche's ADR is up just 2% since the start of the year and it has gained around 20% from its March lows. Despite the recent run, Roche could offer an upside in the near term, as the company's revenues and earnings are expected to see steady gains going forward. While the company's sales were up...